Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Rite Aid Corporation    RAD

Delayed Quote. Delayed  - 01/23 10:00:41 pm
6.9 USD   -7.51%
01/23 RITE AID : Ken Black Named Senior Vice President of Human Resources ..
01/21 RITE AID, WALGR : Report
01/20 FTC NOT SOLD ON : Bloomberg
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 

Rite Aid February Same-Store Sales Rose 3.1%; Up 3% In 4Q

share with twitter share with LinkedIn share with facebook
share via e-mail
0
03/08/2012 | 03:07pm CET

Rite Aid Corp.'s (>> Rite Aid Corporation) same-store sales rose 3.1% in February, marking the 11th straight month of growth for the drug store chain.

The No. 3 U.S. drug store chain behind Walgreen Co. (>> Walgreen Company) and CVS Caremark Corp. (>> CVS Caremark Corporation) reported same-store sales growth in all but one month last year -- March had a 0.1% drop -- with a boost from the rollout of a loyalty program and store renovations that expanded clinical pharmacy services and health and wellness products choices.

During February, same-store sales were up 1.9% in the front of the store. Pharmacy same-store sales increased 3.7%, despite a negative impact of 2.42 percentage points from generic drug introductions. Same-store prescription counts were up 2.2%.

For the fiscal fourth quarter ended March 3, same-store sales improved 3%, including growth of 1.6% in the front of the store and 3.8% in the pharmacy section.

Total February drug store sales rose 2.3% to $2.55 billion. Prescription sales accounted for 68.3% of drugstore sales.

For the quarter, total drug store sales rose 2.5% to $7.12 billion.

Rite-Aid, which has about 4,667 stores, has posted losses since its 2007 acquisition of the Brooks Eckerd Pharmacy chain stores that saddled it with debt just before consumers slashed spending.

The company in December reported that its fiscal third-quarter loss narrowed as same-store sales grew for a fourth consecutive quarter and interest expense and lease termination and write-down charges declined.

Shares were up 1.2% at $1.71 in recent premarket trading. Through Wednesday's close, the stock is up by slightly more than a third this year.

 
   -By Tess Stynes, Dow Jones Newswires; 212-416-2481; Tess.Stynes@dowjones.com 
 

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on RITE AID CORPORATION
01/23 RITE AID CORP : Change in Directors or Principal Officers (form 8-K)
01/23 RITE AID : Ken Black Named Senior Vice President of Human Resources and Chief Hu..
01/21 RITE AID, WALGREENS MERGER PLAN HASN : Report
01/20 FTC NOT SOLD ON WALGREENS' PLAN TO W : Bloomberg
01/17 LEBANON PUBLIC RECORD : Jan. 13 to Jan. 17
01/13 RITE AID : scammer can't dodge date with prison cell, U.S. judge rules
01/12 RITE AID'S DAYS NUMBERED AS WALGREEN : reports
01/12 RITE AID : Foundation Welcomes New Year with New Class of KidCents Charities
01/11 RITE AID : Irvington Police Warn Local Business Owners Of Phone Scam Involving C..
01/11 RITE AID : Shopping center that houses Rite Aid's operational headquarters and D..
More news
Sector news : Retail - Drugs without Grocery
01/20 FTC NOT SOLD ON WALGREENS' PLAN TO W : Bloomberg
01/19DJRival to EpiPen Allergy Treatment to Return to Market--Update
01/19DJRival to EpiPen Allergy Treatment to Return to Market
01/18DJMCKESSON : to Pay $150 Million for Failing to Report 'Suspicious' Drug Orders --..
01/18DJMCKESSON : to Pay $150 Million for Failing to Report 'Suspicious' Drug Orders
More sector news : Retail - Drugs without Grocery
News from SeekingAlpha
01/23 Dissecting The Latest Rite Aid News
01/23 FTC threat still looms over Rite Aid and Fred's
01/20 After Hours Gainers / Losers
01/20 Drugstore investors scramble after FTC wildcard pops up
01/20 Midday Gainers / Losers
Advertisement
Financials ($)
Sales 2017 32 585 M
EBIT 2017 552 M
Net income 2017 69,1 M
Debt 2017 6 989 M
Yield 2017 -
P/E ratio 2017 124,33
P/E ratio 2018 67,82
Capi. / Sales 2017 0,46x
Capi. / Sales 2018 0,24x
Capitalization 7 851 M
More Financials
Chart RITE AID CORPORATION
Duration : Period :
Rite Aid Corporation Technical Analysis Chart | RAD | US7677541044 | 4-Traders
Full-screen chart
Technical analysis trends RITE AID CORPORATION
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 6
Average target price 8,88 $
Spread / Average Target 19%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
John T. Standley Chairman & Chief Executive Officer
Kenneth A. Martindale President & Chief Operating Officer
Darren W. Karst SEVP, Chief Financial & Administrative Officer
Steve Rempel Chief Information Officer & Senior Vice President
Joseph B. Anderson Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
RITE AID CORPORATION-12.38%7 851
RAIA DROGASIL SA3.92%6 640
AIN HOLDINGS INC4.78%2 236
ORIOLA KD OYJ-0.23%834
AUSTRALIAN PHARMACEUTI..-2.91%740
ADCOCK INGRAM HOLDINGS..7.27%666
More Results